SCHEMBL4688554

SCHEMBL4688554

Cc1ccc(-c2c(Cl)[c]ccc2F)cc1C

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.38
PTGS1 P23219 7/20 0.38
NOTUM Q6P988 1/20 0.32
MAP3K14 Q99558 1/20 0.31
MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5778165 0.81 TYMP (0.34) PTGS2
SCHEMBL436848 0.76 NPC1 (0.39) PTGS2NOTUMMAP3K14
SCHEMBL8074688 0.76 ESR1 (0.31)
SCHEMBL17514918 0.75 RAPGEF4 (0.30)
SCHEMBL5182645 0.74 CYP1A2 (0.38)
SCHEMBL17514827 0.73 ABL1 (0.40) PTGS2
SCHEMBL4650408 0.73 MAOA (0.40) MCL1
SCHEMBL9447754 0.71 GRIA1 (0.37)
SCHEMBL9306464 0.71 PTGS2 (0.47) PTGS2PTGS1NOTUMMAP3K14MCL1
SCHEMBL17514784 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603572-A4 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-06-25 EP disclosed
EP-1603572-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-12-14 EP disclosed
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed